Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD.
about
Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trialsPsychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.The quality of life of adults with attention deficit hyperactivity disorder: a systematic reviewPharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategiesSelf-esteem evaluation in children and adolescents suffering from ADHD.Toward quality care in ADHD: defining the goals of treatment.Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective oveThe Norwegian Translation of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale: Validation and Assessment of QoL in 313 Adults With ADHD.Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physiciansFindings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment.ADHD symptoms are differentially related to specific aspects of quality of life.Functional Impairment Mediates the Relationship Between Adult ADHD Inattentiveness and Occupational Outcome.Efficacy of Cognitive Behavioral Therapy With and Without Medication for Adults With ADHD.
P2860
Q34447938-C2C783F0-B07C-4294-AE8F-7021DB8E9517Q35563516-8B603344-4035-4D27-8120-B6D1A0F3AFB9Q36100175-8F388CE3-A513-4CE4-9EBD-E5C8198ABDD5Q36740445-EBE23D39-3780-4D10-A5E6-6444C25656D1Q37025570-FBF65A40-9A5B-4424-8C31-5595101DA9BEQ38082894-82418026-15D0-4F2D-BF26-65010FE90BACQ39028113-1263158A-7232-4D48-A8ED-74894D49C4EBQ39873196-B060E0E7-6528-4543-9D4F-CBDBCE2750DEQ39952803-001B3A54-BCE5-4700-BE63-A063CD5F8609Q43875145-4363C7AA-52F8-423A-888C-A11E573B5DCBQ47676742-B082F833-8C04-4F6C-BBB7-D5BCDBDB3C68Q48299227-D8DFE622-BE42-4FC8-93EA-1F6AF32D9472Q53626856-52995DF9-C7B6-424E-8DF0-AB1C236726F3
P2860
Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of atomoxetine on healt ...... status in patients with ADHD.
@en
Impact of atomoxetine on healt ...... status in patients with ADHD.
@nl
type
label
Impact of atomoxetine on healt ...... status in patients with ADHD.
@en
Impact of atomoxetine on healt ...... status in patients with ADHD.
@nl
prefLabel
Impact of atomoxetine on healt ...... status in patients with ADHD.
@en
Impact of atomoxetine on healt ...... status in patients with ADHD.
@nl
P2093
P2860
P356
P1476
Impact of atomoxetine on healt ...... status in patients with ADHD.
@en
P2093
Jodi M Shorr
Joseph A Johnston
Louis S Matza
Maria N Stoeckl
P2860
P304
P356
10.1586/14737167.6.4.379
P577
2006-08-01T00:00:00Z